Results per Page:
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
SARS-CoV-2 vaccine efficacy in Latin American countries
From the Gilbert Group, Vaccine and Infectious Disease and Public Health Sciences Divisions
Mosaic HIV immunogens boost the breadth of vaccine immune responses
From the Gilbert and McElrath Labs, Vaccine and Infectious Disease Division
A win for vaccines: immune correlates identified for COVID-19
From the Fong, Gilbert, and collaborating labs, Vaccine and Infectious Disease Division & Public Health Sciences Division
Learning from the past to improve SARS-CoV-2 variant discovery
From Dr. Lue Ping Zhao and collaborating labs, Public Health Sciences, Clinical Research, and Vaccine and Infectious Disease Divisions
Does HIV disease progression differ by ancestry?
From Drs. Shuying (Sue) Li and Peter Gilbert, Vaccine and Infectious Disease Division
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Discovering potential emerging SARS-CoV-2 variants
From the Zhao, Gilbert, Geraghty and Jerome labs, a collaboration between Public Health Sciences, Vaccine and Infectious Disease, and the Clinical Research Divisions
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Researchers pinpoint 'correlates of protection' for Moderna vaccine
Findings may make it easier to test COVID-19 vaccine updates to protect against variants
Tip Sheet: Making clinical trials more inclusive, measuring COVID vaccine protection and new HIV vaccine results
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Biostatisticians draft blueprints for COVID-19 vax trials
Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
Numbers don’t lie, but sometimes our brains do
Avoid confusion about statistics in medical research with these hints and resources
Machine learning predicts HIV pseudovirus antibody neutralization
From the Gilbert group, Vaccine and Infectious Disease Division
Closer is better
From the Gilbert group, Vaccine and Infectious Disease Division
Serotype is serious business for Dengue infection
From Gilbert Laboratory, Vaccine and Infectious Disease Division
Computational biologist Dr. Raphael Gottardo receives 2018 Mortimer Spiegelman Award
American Public Health Association recognizes Fred Hutch researcher for his contributions to health statistics biology
5 questions on new dengue vaccine analysis
Asked to help re-examine clinical trial data, Fred Hutch biostatisticians foresee a new era of personalized vaccines
Fong joins HVTN biostatisticians
Interdisciplinary researcher’s methods add to HIV vaccine trials, analysis